A 30-year-old man in Singapore has been diagnosed with mpox clade 1b — the country’s first locally transmitted case of the more severe variant — and he hadn’t left the country. That detail is what makes Thursday’s announcement from the Communicable Diseases Agency (CDA) worth watching.

The man developed symptoms on March 25 and was confirmed infected on March 31. A second case, a 34-year-old who had recent travel history and prolonged physical contact with the first patient, tested positive the following day. Both are in stable condition and isolating at home, according to the CDA. Both infections were likely transmitted through sexual contact.

Contact tracing is ongoing, and high-risk contacts will be offered mpox vaccination as post-exposure prophylaxis.

Singapore has recorded mpox cases before — 23 last year and seven as of March 21, per CDA data. But those were clade II infections or travel-linked clade I cases. These are the first confirmed local transmissions of clade 1b, a strain that emerged among sex workers in the Democratic Republic of Congo in September 2023 and drove surges across African countries in 2024 before appearing in travel-related cases worldwide.

The 30-year-old’s lack of travel history means the virus was already circulating locally before detection. How long, and how widely, remains unclear. For a city-state that serves as one of Asia’s busiest transit hubs, that gap matters — not because the general risk is high (the CDA notes mpox spreads through intimate contact, not casual interaction), but because it raises the question of whether regional surveillance is catching what’s actually circulating or only what walks into a clinic.

The CDA maintains that the risk to the public is low and is not recommending population-wide vaccination. Mpox vaccines are available on a self-paid basis at select clinics, with the National Centre for Infectious Diseases offering them from May 2026.

Sources